We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1B
AUM Growth
-$10.2M
Cap. Flow
-$19.8M
Cap. Flow %
-1.98%
Top 10 Hldgs %
3.73%
Holding
2,077
New
647
Increased
422
Reduced
386
Closed
620

Top Buys

Rank Stock Value
1
WEN icon
Wendy's
WEN
+$4.1M
2
DMC
Del Monte Corp
DMC
+$3.08M
3
SONO icon
Sonos
SONO
+$2.84M
4
IDXX icon
Idexx Laboratories
IDXX
+$2.8M
5
JBSS icon
John B. Sanfilippo & Son
JBSS
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 15.64%
2 Consumer Discretionary 14.23%
3 Healthcare 13.56%
4 Financials 11.82%
5 Industrials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGNT icon
501
Cognyte Software
CGNT
$680M
$728K 0.07%
119,575
-78,422
-40% -$365K
LEVI icon
502
Levi Strauss
LEVI
$9.39B
$728K 0.07%
+50,440
New +$728K
SM icon
503
SM Energy
SM
$6.92B
$728K 0.07%
23,011
-1,440
-6% -$40.7K
KNTE
504
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$728K 0.07%
240,343
+203,220
+547% +$783K
PNFP icon
505
Pinnacle Financial Partners Inc
PNFP
$15.8B
$727K 0.07%
12,827
-28,393
-69% -$1.5M
PLMR icon
506
Palomar
PLMR
$3.45B
$726K 0.07%
12,516
-27,697
-69% -$1.48M
PETQ
507
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$726K 0.07%
47,844
-7,857
-14% -$101K
TNYA icon
508
Tenaya Therapeutics
TNYA
$163M
$724K 0.07%
123,411
+35,243
+40% +$205K
FHLC icon
509
Fidelity MSCI Health Care Index ETF
FHLC
$3.36B
$722K 0.07%
11,440
-5,533
-33% -$347K
AFRM icon
510
Affirm
AFRM
$25.2B
$721K 0.07%
+47,014
New +$624K
RMD icon
511
ResMed
RMD
$30.7B
$720K 0.07%
3,297
-10,967
-77% -$2.44M
PSMT icon
512
Pricesmart
PSMT
$5.46B
$719K 0.07%
+9,715
New +$715K
STKL
513
DELISTED
SunOpta
STKL
$718K 0.07%
107,320
-186,078
-63% -$1.4M
PMVP icon
514
PMV Pharmaceuticals
PMVP
$63.5M
$717K 0.07%
+114,604
New +$601K
EOLS icon
515
Evolus
EOLS
$501M
$715K 0.07%
+98,378
New +$849K
NOMD icon
516
Nomad Foods
NOMD
$1.68B
$715K 0.07%
+40,818
New +$742K
ZGN icon
517
Zegna
ZGN
$4B
$714K 0.07%
+56,281
New +$701K
OII icon
518
Oceaneering
OII
$4.77B
$713K 0.07%
+38,141
New +$657K
USMV icon
519
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
$712K 0.07%
+9,580
New +$700K
EGRX
520
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$711K 0.07%
36,582
+22,358
+157% +$530K
ILPT
521
Industrial Logistics Properties Trust
ILPT
$586M
$710K 0.07%
215,011
-133,388
-38% -$298K
VZIO
522
DELISTED
VIZIO Holding Corp.
VZIO
$710K 0.07%
+105,152
New +$813K
APD icon
523
Air Products & Chemicals
APD
$67.6B
$708K 0.07%
+2,364
New +$673K
ERAS icon
524
Erasca
ERAS
$6.39B
$708K 0.07%
256,671
-44,117
-15% -$126K
GLP icon
525
Global Partners
GLP
$1.7B
$706K 0.07%
22,965
-12,009
-34% -$366K

Similar funds

GSA Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, GSA Capital Partners held 2,077 positions worth $1B, down 1% from $1.01B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners's Q2 2023 filing shows 647 new, 422 increased, 386 reduced and 620 closed positions. Its largest new stake was Sonos: 160,082 shares worth $2.61M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $7.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • GSA Capital Partners's largest Q2 2023 buy was Sonos: 160,082 shares worth $2.61M.
  • GSA Capital Partners added most to Wendy's in Q2 2023, an estimated $4.1M increase.
  • GSA Capital Partners's biggest Q2 2023 reduction was Arlo Technologies, cutting an estimated $3.67M.
  • GSA Capital Partners fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2023, selling an estimated $7.8M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $1B portfolio in Q2 2023.
  • GSA Capital Partners opened 647 new positions and closed 620 in Q2 2023.
  • GSA Capital Partners's portfolio value fell 1% quarter-over-quarter to $1B.

Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.